Target intelligence / Profile preview

Alpha-adrenergic receptor (Alpha-AR) (Alpha-AR)

Target
Alpha-AR
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

Alpha-adrenergic receptors, or alpha-adrenoceptors, are a class of G protein-coupled receptors that mediate the effects of the endogenous catecholamines epinephrine and norepinephrine. They are divided into two main types: alpha-1 and alpha-2, each with further subtypes (alpha-1A, 1B, 1D and alpha-2A, 2B, 2C) [StatPearls, 2023]. Alpha-1 receptors are predominantly located on vascular smooth muscle and the prostate, where their activation leads to vasoconstriction and muscle contraction [NIH, 2022]. In contrast, alpha-2 receptors are often found presynaptically, where they act as autoreceptors to inhibit the further release of norepinephrine, providing a feedback loop for the sympathetic nervous system [PubMed, 2021]. Therapeutically, alpha-1 antagonists like tamsulosin are used to treat benign prostatic hyperplasia, while alpha-1 agonists like phenylephrine serve as decongestants [PubChem, 2024]. Alpha-2 agonists such as clonidine are utilized for hypertension and ADHD management due to their central sympatholytic effects [StatPearls, 2023]. Understanding the distribution and signaling pathways of these receptors is critical for managing cardiovascular and urological conditions.

Other names
Alpha-adrenoceptorAdrenoceptor alphaAlpha-adrenergic receptor family
02

Mechanism of action

Alpha-adrenergic receptors function as G protein-coupled receptors that respond to endogenous catecholamines. Alpha-1 receptors primarily couple to Gq proteins, activating phospholipase C to increase intracellular calcium and induce smooth muscle contraction. Alpha-2 receptors primarily couple to Gi proteins, inhibiting adenylyl cyclase to decrease cAMP levels and modulate neurotransmitter release.

03

Biological functions

Signal transductionVasoconstrictionSmooth muscle contractionInhibition of neurotransmitter releasePlatelet aggregation
04

Disease associations

HypertensionBenign prostatic hyperplasiaGlaucomaNasal congestionCardiovascular diseaseAttention deficit hyperactivity disorder (ADHD)
05

Safety considerations

Orthostatic hypotensionReflex tachycardiaSedationDry mouthNasal congestionFirst-dose phenomenon
06

Interacting drugs

Phentolamine

8 more in the full profile.

07

Biomarkers

Blood pressureHeart rateIntraocular pressureUrinary flow rate (Qmax)

Beyond the preview

Go deeper on Alpha-adrenergic receptor (Alpha-AR) (Alpha-AR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-adrenergic receptor (Alpha-AR) (Alpha-AR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call